[CAS NO. 92562-88-4]  Lagociclovir

Lagociclovir (FLG) (6 days) shows inhibitory activity with IC ₅₀ s of 8 ± 3.8, 9 ± 2.5, 13 ± 3.4 and 15 ± 6.8 μM against 3TC-R HBV , wt HBV , PMEA-R HBV and 3TC+PMEA-R HBV , respectively in transiently transfected Huh7 cells ^[1] .
Lagociclovir (0-100 μM; 6 days) inhibits the replication of wild-type and drug-resistant mutants of HBV in transiently transfected Huh7 cells ^[1] .

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.